Global Dental Burs Market 2024
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
$2,750.00
Isotretinoin is a medication used to treat severe acne that has not responded to other treatments. It is a type of retinoid, a form of vitamin A, that works by decreasing the production of sebum in the skin and reducing inflammation. Isotretinoin is available under various brand names, including Accutane, Claravis, and Absorica, and is typically prescribed by a dermatologist. In 2022, the global isotretinoin drugs market stood at USD 1,321.0 million. Recording a CAGR of 4.49% from 2023 to 2029, the worth is projected to reach ~USD 1,796.5 million by 2029, according to the latest market data.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global isotretinoin drugs market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the form, indication, distribution channel, and region. The global market for isotretinoin drugs can be segmented by form: capsule, injection. In 2022, the capsule segment made up the largest share of revenue generated by the isotretinoin drugs market. Isotretinoin drugs market is further segmented by indication: severe acne, squamous cell carcinoma, cutaneous T- cell lymphoma, neuroblastoma, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressive (FOP), others. The severe acne segment was the largest contributor to the global isotretinoin drugs market in 2022. Based on distribution channel, the isotretinoin drugs market is segmented into: hospital pharmacies, retail pharmacies, online pharmacies. The hospital pharmacies segment is estimated to account for the largest share of the global isotretinoin drugs market. On the basis of region, the isotretinoin drugs market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global isotretinoin drugs market in 2022 and is anticipated to hold its share during the forecast period.
Market Segmentation
By form: capsule, injection
By indication: severe acne, squamous cell carcinoma, cutaneous T- cell lymphoma, neuroblastoma, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressive (FOP), others
By distribution channel: hospital pharmacies, retail pharmacies, online pharmacies
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides analysis of the key companies of the industry and their detailed company profiles including Douglas Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Ltd., F. Hoffmann-La Roche Ltd., Sun Pharmaceuticals Industries Limited, Viatris Inc., Chongqing Huapont Shengchem Pharm. Co., Ltd., Cipher Pharmaceuticals Inc., GlaxoSmithKline plc, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
• To analyze and forecast the market size of the global isotretinoin drugs market.
• To classify and forecast the global isotretinoin drugs market based on form, indication, distribution channel, region.
• To identify drivers and challenges for the global isotretinoin drugs market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global isotretinoin drugs market.
• To identify and analyze the profile of leading players operating in the global isotretinoin drugs market.
Why Choose This Report
• Gain a reliable outlook of the global isotretinoin drugs market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY FORM
Capsule
Injection
PART 6. MARKET BREAKDOWN BY INDICATION
Severe acne
Squamous cell carcinoma
Cutaneous T- cell lymphoma
Neuroblastoma
Harlequin ichthyosis
Xeroderma pigmentosum
Fibrodysplasia ossificans progressive (FOP)
Others
PART 7. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL
Hospital pharmacies
Retail pharmacies
Online pharmacies
PART 8. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 9. KEY COMPANIES
Douglas Pharmaceuticals Limited
Teva Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories, Ltd.
F. Hoffmann-La Roche Ltd.
Sun Pharmaceuticals Industries Limited
Viatris Inc.
Chongqing Huapont Shengchem Pharm. Co., Ltd.
Cipher Pharmaceuticals Inc.
GlaxoSmithKline plc
DISCLAIMER
Douglas Pharmaceuticals Limited
Teva Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories, Ltd.
F. Hoffmann-La Roche Ltd.
Sun Pharmaceuticals Industries Limited
Viatris Inc.
Chongqing Huapont Shengchem Pharm. Co., Ltd.
Cipher Pharmaceuticals Inc.
GlaxoSmithKline plc
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2022 |
Forecast Year | 2023-2029 |
CAGR (2023-2029) | 4.49% |
Pages | 87 |
Key Players | Douglas Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Sun Pharmaceuticals Industries Limited, Viatris Inc., Chongqing Huapont Shengchem Pharm. Co. Ltd., Cipher Pharmaceuticals Inc., GlaxoSmithKline plc |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.